HF 2533 Minnesota House · 2025-2026 Regular Session

Prior authorization mental health carve out expanded.

HF 2533 expands exemptions from prior authorization requirements for specific mental health medications in Minnesota. It prevents insurance plans from requiring prior approval for certain atypical antipsychotics, antidepressants, or antianxiety drugs used to treat mental illness if no generic equivalent exists, the drug was prescribed before July 2003, or it's part of a patient's current treatment. The bill also automatically grants 60 days of prior authorization approval when a generic version becomes available for a drug already in a patient's treatment plan. This directly affects mental health patients prescribed these medications, ensuring continuity of care without extra administrative barriers. The changes apply to all state Medicaid and insurance plans covering these drugs.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 20, 2025 Last action Mar 24, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
0
Mar 20, 2025
Introduced
Introduction and first reading, referred to Human Services Finance and Policy
lower
1 primary · 1 co-sponsor

Sponsors